10X Genomics Inc
NASDAQ:TXG
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
10X Genomics Inc
NASDAQ:TXG
|
US |
|
I
|
Icade SA
OTC:CDMGF
|
FR |
|
Jiangsu Hengrui Pharmaceuticals Co Ltd
SSE:600276
|
CN |
|
P
|
Paladin Energy Ltd
DUS:PUR
|
AU |
|
Nomura Research Institute Ltd
OTC:NRILY
|
JP |
|
C
|
Cleanaway Waste Management Ltd
F:TG9
|
AU |
|
First National of Nebraska Inc
OTC:FINN
|
US |
|
A
|
Andritz AG
XMUN:AZ2
|
AT |
|
W
|
Welsbach Technology Metals Acquisition Corp
OTC:WTMA
|
US |
Wall St Price Targets
TXG Price Targets Summary
10X Genomics Inc
According to Wall Street analysts, the average 1-year price target for TXG is 28.17 USD with a low forecast of 20.2 USD and a high forecast of 42 USD.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is TXG's stock price target?
Price Target
28.17
USD
According to Wall Street analysts, the average 1-year price target for TXG is 28.17 USD with a low forecast of 20.2 USD and a high forecast of 42 USD.
What is the Revenue forecast for 10X Genomics Inc?
Projected CAGR
10%
Over the last 7 years, the compound annual growth rate for Revenue has been 24%. The projected CAGR for the next 8 years is 10%.
What is the Gross Profit forecast for 10X Genomics Inc?
Projected CAGR
10%
Over the last 7 years, the compound annual growth rate for Gross Profit has been 21%. The projected CAGR for the next 8 years is 10%.
